Analyst Thinks Johnson & Johnson Could Hit a $280 Target
A major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Evaluate which tax lot harvesting approach—ETFs or mutual funds—yields lower taxes in retirement and aligns with your plan.
25,078 articlesA major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Finding value in semiconductors is tough, but a disciplined approach can spot opportunities amid rapid tech change. L...
Tether converts a historic $13 billion profit into a bold health-tech investment, backing Eight Sleep at a $1.5 billi...
Microsoft stock slid about 25% in Q1 2026, its worst showing in years, as AI spending accelerates yet revenue signals...
Hut 8 is pivoting to AI data center infrastructure, prompting a Canaccord upgrade that nearly doubles the firm’s pric...
A long-dormant market indicator has flashed, raising questions about the pace of the rally as the midterm election cy...
This deep-dive breaks down veru (veru) 2026 earnings, translating the quarterly numbers into a clear sense of cash he...
Oracle’s latest quarterly results revived the debate around a potential oracle price prediction: $245 as cloud moment...
A regional Amazon-like player in LATAM sits near its 52-week low. This article breaks down why MercadoLibre stands ou...
A risk disclosure in SpaceX’s pre-IPO paperwork flags space-based warfare threats to Starlink. As investors watch an ...
The surge in digital payments and online lending has unlocked fresh opportunities in fintech. This guide shows you ho...
New to investing? This beginner's guide to investment analysis breaks down how to read financials, estimate intrinsic...